Health Care & Life Sciences » Pharmaceuticals | YungShin Global Holding Corp.

YungShin Global Holding Corp. | Cash Flow

Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
755
932
1,111
761
621
933
Depreciation, Depletion & Amortization
373
320
317
328
331
355
Other Funds
-
-
8
8
17
191
Funds from Operations
1,032
1,126
1,147
807
716
1,097
Changes in Working Capital
191
38
591
161
192
148
Net Operating Cash Flow
1,224
1,164
556
647
524
949
Capital Expenditures
301
432
539
307
831
Sale of Fixed Assets & Businesses
-
-
13
49
2
Purchase/Sale of Investments
4
1
8
-
7
Net Investing Cash Flow
562
565
544
1,129
859
Cash Dividends Paid - Total
457
507
507
666
400
Issuance/Reduction of Debt, Net
157
28
344
997
725
Net Financing Cash Flow
299
480
171
323
342
Net Change in Cash
402
157
117
129
58
Free Cash Flow
944
740
23
351
195
Net Assets from Acquisitions
192
-
-
753
23
Other Sources
-
-
-
1
-
Exchange Rate Effect
40
38
42
30
65
Other Uses
66
135
9
118
-

About YungShin Global Holding

View Profile
Address
25th Floor-1, 402 Shizheng Road
Taichung TX 407 57
Taiwan
Employees -
Website http://www.yungshingroup.com
Updated 07/08/2019
YungShin Global Holding Corp. engages in resources integration and business development. Its business scopes include research, development, and manufacture of pharmaceutical products (generic and branded drugs), active pharmaceutical ingredients; and healthcare and beauty care products. The company was founded on January 3, 2011 and is headquartered in Taichung, Taiwan.